Cairo – Mubasher: An Egyptian-Japanese-Singaporean alliance signed a shareholders' agreement to establish a factory for the local production of blood collection bags and tubes in the Suez Canal Economic Zone in Ain Sokhna. The plant is a partnership between the Egyptian Company for Medical Investments, Japan's JMS , and Interpharm for Medical Industries, with investments of EGP 1.4 billion.

This agreement falls within the framework of the Egyptian state's strategic direction to promote local industry and localize medical technology industries, including medical products, supplies, and devices. It represents an implementation of the previous announcement of the launch of a project to manufacture blood collection bags and containers locally.

A joint cooperation agreement was signed between the Egyptian Company for Medical Investments (ECMI), affiliated with the Egyptian Authority for Unified Procurement, and the Japanese company JMS , a world leader in manufacturing high-quality blood collection bags and bladders and other medical supplies, and Interpharm, a company specializing in import, export, and medical industries and the exclusive agent of the Japanese company JMS , to manufacture blood collection bags and bladders locally according to international specifications, which will contribute to securing health needs and increasing medical exports .

Prime Minister Dr. Mostafa Madbouly, who attended the signing ceremony, emphasized that this promising project is one of the pillars of an integrated national project aimed at the Egyptian state, aiming to transfer advanced technology and localize industries in strategic and vital sectors, most notably the pharmaceutical and medical industries, which impact citizens' lives and are linked to their health .

The Prime Minister commended the agreement concluded today to implement a project to produce blood collection bags and pouches locally, through a partnership that achieves integration between the public and private sectors to advance the medical industries sector in Egypt in all its branches, in order to meet the needs of the local market and open up export prospects to neighboring markets, in light of the potential to achieve a real boom and build an integrated medical industrial base .

Dr. Hesham Steit, Chairman of the Egyptian Authority for Unified Procurement, Medical Supply and Technology Management, stated that the project aims to ensure the quality and safety of blood transfusions in accordance with international standards, improve healthcare services for patients, and develop the medical industry through the transfer of advanced technology and the localization of expertise.

The project aims to meet 100% of the Egyptian market's annual blood bag needs, while increasing exports to the Middle East and North Africa. The project targets the production of 7 million blood bags by the seventh year, 3 million of which will be for local consumption and 4 million for export. This will contribute to boosting Egypt's medical product exports and increasing foreign currency earnings .

Dr. Hesham State added that the factory will be built in the Suez Canal Economic Zone in Ain Sokhna, covering an area of 7,000 square meters, including sterile production areas and advanced warehouses. This will benefit from the government incentives and logistical facilities offered by the zone, making it an ideal manufacturing base for regional and international markets .

The head of the Egyptian Unified Procurement Authority pointed out that this massive investment alliance consists of the Egyptian Company for Medical Investments (ECMI) , Interpharm Medical Industries, and the Japanese company JMS , and that investments totaling 1.4 billion Egyptian pounds will be pumped into it .